MAHLY (Medipal Holdings) Tax Expense: $188 Mil (TTM As of Mar. 2026)


MAHLY Medipal Holdings Corp MAHLY
81 GF Score
Price $17.00
GF Value $16.37
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Medipal Holdings Tax Expense?

Medipal Holdings MAHLY 81 Tax Expense is $188 Mil as of Mar. 2026. GuruFocus rates MAHLY with a GF Score™ of 81/100 and a GF Value™ of $16.37 (Fairly Valued). The stock has 1 warning sign investors should review.

Medipal Holdings's tax expense for the months ended in Mar. 2026 was $50 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was $188 Mil.


Medipal Holdings  (OTCPK:MAHLY) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Medipal Holdings Tax Expense Related Terms


Medipal Holdings Tax Expense Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Tax Expense Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152.53 162.63 153.34 169.08 180.88

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.11 41.89 42.41 54.18 49.98
MAHLY
81GF Score
Medipal Holdings Corp MAHLY
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $188 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of $188 Mil mean?
Medipal Holdings (MAHLY) has a Tax Expense of $188 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Tax Expense too high?
Medipal Holdings' current Tax Expense is $188 Mil. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Tax Expense compare to MCK and CAH?
Medipal Holdings' Tax Expense of $188 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Distribution company?
A good Tax Expense depends on the Medical Distribution industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Tax Expense is $188 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.37, compared to a current price of $17.00 — trading 3.8% above its estimated fair value. The current Tax Expense is $188 Mil. Medipal Holdings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Tax Expense is $188 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (MAHLY) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of $17.00 is trading 3.8% above its estimated GF Value™ of $16.37. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for MAHLY:

  • Tax Expense: $188 Mil
  • GF Value™: $16.37 vs. price of $17.00 (3.8% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medipal Holdings Business Description

Other Exchanges MEPDF:USA7459:Japan
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score

Get the complete analysis for MAHLY

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price
$16.37
GF Value